Finance and funding: latest news

Finance and funding features

Finance and funding news from aidsmap

More news

Finance and funding news selected from other sources

  • EXCLUSIVE: Government confirms it will not cut HIV prevention budget

    The Government has refuted claims that it was to halve its HIV prevention budget for 2015, reiterating support for the strategy and saying “It will continue”.

    9 hours ago | PinkNews
  • Congress adds $300 million to PEPFAR for FY15, in bill global health advocates say recognizes critical needs

    The allotment of $4.3 billion for PEPFAR restores half of the $600 million in cuts PEPFAR has seen since 2011.

    16 December 2014 | Science Speaks
  • NAT opposes 50% cut to national HIV prevention funding for England

    The Government has announced that there will be devastating cuts to funding for the national HIV prevention programme in England.  Funding will be halved for the year commencing April 2015 and there is as yet no commitment to fund further years of the programme.  

    15 December 2014 | NAT press release
  • HIV dollars drop with waning philanthropic funds

    Last year saw the lowest level of funding from charitable donors since 2007, the year when government spending on HIV began to drop. While the report notes that philanthropic support accounted for just three percent of all international funding for HIV-related efforts in low and middle-income countries, it has increasingly been cited in recent years as a source of support to fill gaps left by constricting national budgets.

    10 December 2014 | Science Speaks
  • Appeal to global donors to save the Treatment Action Campaign

    Fulfilling the right to health depends on common purpose between researchers, clinicians, and activists. On the eve of World AIDS Day 2014 (Dec 1), we write this letter as scientists and academics who are concerned about the possible closure of the Treatment Action Campaign (TAC) in South Africa as a consequence of serious funding difficulties.

    05 December 2014 | The Lancet
  • Over $1 billion saved by 2028 through Medicines Patent Pool licensing agreements

    Since 2010, UNITAID’s investments in the MPP have yielded 2.6 times the value of its funding through such licensing deals. Between 2010 and 2028, this return on investment is projected to generate between $1.18 - $1.4 billion in savings due to price reductions through generic product manufacturing of key HIV medicines.

    02 December 2014 | UNITAID
  • NHS asks Nice to delay ground-breaking hepatitis C drug

    Nice is due to finish its final assessment of sofosbuvir in January. It is usual for them to give the NHS three months to find the money or put staff – if needed – in place. NHS England is thought to have asked them to delay this by six months.

    19 November 2014 | Channel 4 News (blog)
  • South Africa to spend $2.2 billion on HIV drugs in next two years

    South Africa plans to spend $2.2 billion over two years to buy HIV/AIDS drugs for public hospitals, a government minister said on Monday, as a study shows the prevalence of the virus is rising.

    18 November 2014 | Reuters
  • UK has 'signed a death warrant' for South Africans with HIV-Aids

    One of the world’s leading Aids activists has accused Britain of “signing a death warrant” for South Africans in need of treatment after withdrawing aid from the Treatment Action Campaign, which now faces ruin.

    05 November 2014 | The Guardian
  • TB activists call for a bigger piece of the pie from the Global Fund

    Today (October 31) TB activists interrupted the plenary session at the 45th Conference on Lung Health, calling on the Global Fund and partners to increase the amount of funds allocated to TB without jeopardizing funding to HIV and malaria and other diseases.

    04 November 2014 | TB Online
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.